Office of Diversion Control, US Department of Justice, Drug Enforcement Administration

ABOUT US > What's New

What's New

August

Rhodes Technologies (August 31, 2015)

Catalent CTS, LLC (August 31, 2015)

Alltech Associates, Inc. (August 31, 2015)

Catalent Pharma Solutions, LLC (August 31, 2015)

Noramco, Inc. (August 31, 2015)

Cambrex Charles City (August 31, 2015)

Johnson Matthey Pharmaceutical Materials, Inc. (August 31, 2015)

Victor B. Williams, M.D.; Decision and Order (August 18, 2015)

John R. Kregenow, D.D.S.; Decision and Order (August 18, 2015)

Ronald A. Green, M.D.; Decision and Order (August 18, 2015)

Nicholas Nardacci, M.D.; Decision and Order (August 18, 2015)

Jeffrey S. Holverson, M.D.; Decision and Order (August 18, 2015)

Arthur H. Bell, D.O.; Decision and Order (August 18, 2015)

Matthew Valentine/Liar Catchers; Order (August 18, 2015)

Devra Hamilton, N.P.; Decision and Order (August 18, 2015)

Cody Laboratories, Inc. (August 18, 2015)

IRIX Manufacturing, Inc. (August 18, 2015)

Alltech Associates, Inc. (August 18, 2015)

Austin Pharma LLC (August 18, 2015)

Placement of Eluxadoline Into Schedule IV (August 11, 2015)

Special Report: Opiates and Related Drugs Reported in NFLIS, 2009-2014

Patheon Pharmaceuticals, Inc. (August 5, 2015)

Adeline Davies Essien, M.D.; Decision and Order (August 4, 2015)

Pedro E. Lopez, M.D.; Decision and Order (August 4, 2015)

AIM Pharmacy & Surgical S. Corp. Order (August 4, 2015)

Research Triangle Institute (August 4, 2015)

Johnson Matthey, Inc. (August 4, 2015)

Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC (August 4, 2015)

Hospira (August 4, 2015)

Actavis Laboratories FL, Inc. (August 4, 2015)

Almac Clinical Services Inc. (ACSI) (August 4, 2015)

Meridian Medical Technologies (August 4, 2015)

Cedarburg Pharmaceuticals, Inc. (August 4, 2015)

Sigma Aldrich Research Biochemicals, Inc. (August 4, 2015)

National Center for Natural Products Research (NIDA MPROJECT), Inc. (August 4, 2015)

Cayman Chemicals Company (August 4, 2015)

Cody Laboratories, Inc. (August 4, 2015)

Johnson Matthey, Inc. (August 4, 2015)

Pharmacore, Inc. (August 4, 2015)

Cambrex Charles City (August 4, 2015)


July

Stepan Company (July 30, 2015)

Pharmacore (July 30, 2015)

Apertus Pharmaceuticals (July 30, 2015)

Cambridge Isotope Lab (July 30, 2015)

American Radiolabeled Chemicals, Inc. (July 30, 2015)

Syed Jawed Akhtar-Zaidi, M.D.; Decision and Order (July 20, 2015)

Temporary Placement of Acetyl Fentanyl Into Schedule I (July 17, 2015)

Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2016 (July 17, 2015)

Meda Pharmaceuticals, Inc. (July 17, 2015)

Siegfried USA, LLC (July 17, 2015)

Siegfried USA, LLC (July 17, 2015)

Mallinckrodt, LLC (July 17, 2015)

Navinta LLC (July 17, 2015)

Odette L. Campbell, M.D.; Decision and Order (July 14, 2015)

Trenton F. Horst, D.O.; Decision and Order (July 14, 2015)

Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015 (July 8, 2015)

United States Pharmacopeial Convention (July 6, 2015)

Kremers Urban Pharmaceuticals, Inc. (July 6, 2015)

Lipomed, Inc. (July 6, 2015)

Mylan Pharmaceuticals, Inc. (July 6, 2015)

AMPAC Fine Chemicals LLC (July 6, 2015)

Navinta, LLC (July 6, 2015)

Johnson Matthey, Inc. (July 6, 2015)

Halo Pharmaceutical, Inc. (July 6, 2015)

Rhodes Technologies (July 6, 2015)

Euticals, Inc. (July 6, 2015)

Noramco, Inc. (July 6, 2015)


June

Insys Therapeutics, Inc. (June 30, 2015)

Midas Pharmaceuticals, Inc. (June 23, 2015)

Wildlife Laboratories, Inc. (June 23, 2015)

Adjusted Aggregate Production Quotas for Difenoxin, Diphenoxylate (for Conversion), and Marijuana (June 17, 2015)

2015 Established Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids (June 17, 2015)

Mylan Technologies, Inc. (June 17, 2015)

Siemens Healthcare Diagnostics, Inc. (June 17, 2015)

Mallinckrodt LLC; Correction (June 8, 2015)

S & B Pharma, Inc.; Correction (June 8, 2015)

Removal of [123I]Ioflupane From Schedule II of the Controlled Substances Act (June 3, 2015)


May

Myoderm (May 21, 2015)

Mylan Pharmaceuticals, Inc. (May 21, 2015)

Noramco, Inc. (May 21, 2015)

Mallinckrodt, LLC (May 21, 2015)

Fisher Clinical Services, Inc. (May 21, 2015)

PCAS-Nanosyn, LLC (May 21, 2015)

Temporary Placement of Acetyl Fentanyl into Schedule I (May 21, 2015)

The Main Pharmacy; Decision and Order (May 20, 2015)

Keith Ky Ly, D.O.; Decision and Order (May 20, 2015)

Cove Inc., D/B/A Allwell Pharmacy; Decision and Order (May 20, 2015)

Farmacia Yani; Decision and Order (May 20, 2015)

Jana Marjenhoff, D.O.; Decision and Order (May 20, 2015)

Karen S. Dunning, N.P.; Decision and Order (May 19, 2015)

Bobby D. Reynolds, N.P., Tina L. Killebrew, N.P. and David R. Stout, N.P.; Decision and Orders (May 19, 2015)

JM Pharmacy Group, Inc., d/b/a Farmacia Nueva and Best Pharma Corp; Decision and Order (May 19, 2015)

Maryanne Phillips-Elias, M.D.; Decision and Order (May 19, 2015)

Sharad C. Patel, M.D.; Decision and Order (May 19, 2015)

Annicol Marrocco, M.D.; Decision and Order (May 19, 2015)

Cambrex Charles City (May 15, 2015)

Extension of Temporary Placement of UR-144, XLR11, and AKB48 in Schedule I of the Controlled Substances Act (May 15, 2015)

Placement of UR-144, XLR11, and AKB48 Into Schedule I (May 14, 2015)


April

Unither Manufacturing, LLC (April 22, 2015)

Sigma-Aldrich International GMBH, Sigma Aldrich Co., LLC (April 22, 2015)

Pharmacore (April 22, 2015)

Meridian Medical Technologies (April 22, 2015)

Actavis Laboratories FL, Inc. (April 22, 2015)

Rhodes Technologies (April 22, 2015)

Almac Clinical Services Inc. (ACSI) (April 22, 2015)

Johnson Matthey, Inc. (April 22, 2015)

Stepan Company (April 22, 2015)

Siegfried USA, LLC (April 22, 2015)

Cedarburg Pharmaceuticals, Inc. (April 22, 2015)

Actavis Pharma, Inc. (April 22, 2015)

Johnson Matthey Pharmaceutical Materials, Inc. (April 22, 2015)

Pharmacore, Inc. (April 22, 2015)

Stepan Company (April 22, 2015)

Noramco, Inc. (April 22, 2015)

Cambrex Charles City (April 22, 2015)

Sigma Aldrich Research Biochemicals, Inc. (April 22, 2015)

Cayman Chemicals Company (April 22, 2015)

National Center for Natural Products Research (NIDA MProject), Inc. (April 22, 2015)

AMRI Rensselaer, Inc. (April 22, 2015)

Cody Laboratories, Inc. (April 22, 2015)

Proposed Adjustments to the Aggregate Production Quotas for Difenoxin, Diphenoxylate (for conversion), and Marijuana (April 8, 2015)

30-Day Notice (Extension): Reports of Regulated Transactions Involving Extraordinary Quantities, Uncommon Methods of Payment, and Unusual/Excessive Loss or Disappearance, and Regulated Transactions in Tableting/Encapsulating Machines (April 3, 2015)

30-Day Notice (Extension): Application for Registration Renewal, Affidavit for Chain Renewal (DEA Forms 225, 225a and 225b) (April 3, 2015)

30-Day Notice (Extension): Application for Registration and Application for Registration Renewal (DEA Forms 363 and 363a) (April 3, 2015)


March

Hospira (March 27, 2015)

Meda Pharmaceuticals, Inc. (March 27, 2015)

Mylan Pharmaceuticals, Inc. (March 27, 2015)

Apertus Pharmaceuticals (March 27, 2015)

Patheon Pharmaceuticals, Inc. (March 24, 2015)

Penick Corporation (March 24, 2015)

2015 Proposed Aggregate Production Quotas for Three Temporarily Controlled Synthetic Cannabinoids (March 20, 2015)

Substances Temporarily Controlled Under Schedule I of the Controlled Substances Act (March 20, 2015)

Emergency Disaster Relief
Got Drugs? Turn in your unused or expired medication for safe disposal here.
Alert! Extortion Scam

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Office of Diversion Control  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539